Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
about
Right ventricular dysfunction in chronic lung diseaseRight Atrium Volume Index in Patients with Secondary Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease.Pulmonary hypertension and right heart dysfunction in chronic lung disease.Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary diseaseUse of pulmonary arterial hypertension-specific therapy in overweight or obese patients with obstructive sleep apnea and pulmonary hypertension.Signaling pathways in the epithelial origins of pulmonary fibrosisDecreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis.Lung transplantation for pulmonary hypertension.NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal miceAcute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary diseaseUse of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centersDeterminants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertensionmiR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.High levels of zinc-protoporphyrin identify iron metabolic abnormalities in pulmonary arterial hypertension.Iptakalim, a novel ATP-sensitive potassium channel opener, inhibits pulmonary arterial smooth muscle cell proliferation by downregulation of PKC-α.Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.Prevalence and Characteristics of Pulmonary Hypertension Associated with COPD - A Pilot Study in Patients Referred to a Pulmonary Rehabilitation Program ClinicHeart-lung interaction via infectionCardiopulmonary exercise testing in the assessment of pulmonary hypertension.Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.Expression variations of connective tissue growth factor in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease.Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease.The Dark Side of the Moon: The Right Ventricle.NOX4 expression and distal arteriolar remodeling correlate with pulmonary hypertension in COPD.Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapiesHypoxic pulmonary vasoconstrictionLong-term oxygen therapyHistopathologische Aspekte der pulmonalen Hypertonie
P2860
Q27002670-54F314C5-360D-4D56-BC67-361DB42B7BEFQ30385148-C195E83B-6C15-4381-BA5B-C1F987E7E4E0Q30432299-01CA18A8-0B52-4C44-A405-ECAF248219B7Q33765096-C7509630-83BE-4D68-8CAF-63D67342F927Q33806041-E69C25E9-5F80-441B-85A1-5685DC17B1FFQ34582154-2B5E3E22-3E76-4188-9AE0-15FCBD152C8FQ34665155-3EBEC9CC-3BF0-47AB-B408-4695990E7130Q35290234-E2909843-541E-4826-A394-148931A586DBQ35412426-1AC8F407-3813-49CD-AD26-A148EA9962B4Q35601485-EAEB8400-61D0-4CA8-BFC2-2C587387CB42Q35665739-FC89EBA3-D19A-4C61-AE8B-46A43DFEA886Q35665777-A103FFEB-EC11-4832-B297-9D28D95A8718Q35825326-CC26794F-CDBB-47C0-94F4-A79703873A2CQ35850316-4F8B0DC1-E18A-44E7-B760-32F95A8C6751Q36619246-94190BF9-A1BB-4266-9412-ACDD2AE33C90Q36682039-62DCA5E1-2238-4355-A1F2-3F82E4E7D8F7Q36709815-581DBDBD-78BD-4BAB-AE11-9F199C7ABE03Q36832901-01D3FFA8-16F4-4A10-84FE-9340938B78F3Q37405956-BEE16A8E-9CEC-42C6-9FEB-B6B9ADFB8A42Q37679759-AE897F21-3C72-4F85-88B6-212A79111F3EQ37867677-3E25408C-9182-4718-8259-EA3622384AFEQ38112387-A420492E-C517-41D9-9FF1-CF642BD94DF3Q38827976-E95A6287-4482-4ABB-9EEC-D36EE002BE9DQ39150404-B11A4051-BAE0-44AF-9248-B1FE4BC9C241Q41905315-9CF6352A-88E2-405E-8DC1-8CEA9CFDE973Q44232234-6D23B4FE-3FE6-47BD-918F-87D9026E7247Q47252779-A43DD295-DD88-4AA4-8856-ED8A8C548CBAQ49634236-31E74CD8-B9E9-418D-AE9B-96F3339F8B6AQ55648659-93E82455-6F3E-4B0D-9747-34E06819C8D0Q56978031-00C438C1-3108-4F2C-A8A7-031435C94508Q57099542-5C07CF17-7B2F-4DA5-901D-0E29E5E72A9BQ57749735-9765BC33-0F9A-4DCC-BCE4-B24515736096Q57824017-5B430D8B-9AD5-4612-A106-BBFBD1B77A29
P2860
Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pulmonary hypertension in chro ...... nd interstitial lung diseases.
@en
Pulmonary hypertension in chro ...... nd interstitial lung diseases.
@nl
type
label
Pulmonary hypertension in chro ...... nd interstitial lung diseases.
@en
Pulmonary hypertension in chro ...... nd interstitial lung diseases.
@nl
prefLabel
Pulmonary hypertension in chro ...... nd interstitial lung diseases.
@en
Pulmonary hypertension in chro ...... nd interstitial lung diseases.
@nl
P2093
P356
P1476
Pulmonary hypertension in chro ...... and interstitial lung diseases
@en
P2093
Ari Chaouat
Emmanuel Weitzenblum
Matthieu Canuet
P304
P356
10.1055/S-0029-1233315
P577
2009-07-24T00:00:00Z